Company Analysis Amgen
1. Summary
Advantages
- Dividends (2.92%) are higher than the sector average (0.5467%).
- The stock's return over the last year (7.18%) is higher than the sector average (-28.78%).
- The company's current efficiency (ROE=107.78%) is higher than the sector average (ROE=9.48%)
Disadvantages
- Price (306.86 $) is higher than fair price (143.28 $)
- Current debt level 66.51% has increased over 5 years from 50.08%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
18 november 17:52 FTC sues to stop Amgenβs $27.8B deal for Horizon Therapeutics
18 november 16:20 Biden pushes Congress to allow Medicare to negotiate drug prices
2.3. Market efficiency
| Amgen | Healthcare | Index | |
|---|---|---|---|
| 7 days | -2.8% | -21.6% | -2% |
| 90 days | 16% | -28.5% | -12.1% |
| 1 year | 7.2% | -28.8% | 6.4% |
AMGN vs Sector: Amgen has outperformed the "Healthcare" sector by 35.97% over the past year.
AMGN vs Market: Amgen has outperformed the market by 0.8132% over the past year.
Stable price: AMGN is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AMGN with weekly volatility of 0.1381% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (306.86 $) is higher than the fair price (143.28 $).
Price is higher than fair: The current price (306.86 $) is 53.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (22.76) is lower than that of the sector as a whole (57.09).
P/E vs Market: The company's P/E (22.76) is lower than that of the market as a whole (48.45).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (24.53) is higher than that of the sector as a whole (4.61).
P/BV vs Market: The company's P/BV (24.53) is higher than that of the market as a whole (3.38).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (5.42) is lower than that of the sector as a whole (33.5).
P/S vs Market: The company's P/S indicator (5.42) is lower than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (26.16) is higher than that of the sector as a whole (-19.46).
EV/Ebitda vs Market: The company's EV/Ebitda (26.16) is higher than that of the market as a whole (15.44).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -1.5% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-1.5%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (38.84%).
5.4. ROE
ROE vs Sector: The company's ROE (107.78%) is higher than that of the sector as a whole (9.48%).
ROE vs Market: The company's ROE (107.78%) is higher than that of the market as a whole (8.97%).
5.5. ROA
ROA vs Sector: The company's ROA (6.91%) is higher than that of the sector as a whole (0.1068%).
ROA vs Market: The company's ROA (6.91%) is higher than that of the market as a whole (6.3%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (17%) is higher than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (17%) is higher than that of the market as a whole (10.96%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.92% is higher than the average for the sector '0.5467%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.92% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 2.92% has been growing over the last 5 years. Growth over 5 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (67.83%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
